Stay updated on Pembrolizumab & Blinatumomab in ALL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Blinatumomab in ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Blinatumomab in ALL Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the prior notices about funding lapses and operating status (Revision: v3.4.1).
    Difference
    0.4%
    Check dated 2026-02-11T14:20:36.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Notice about government funding lapse added, stating the NIH Clinical Center is open and directing users to opm.gov for updates. The site revision label was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:36:23.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Added a glossary display option and updated footer/version information to show 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the older items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T06:11:17.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.3.4 has been added, and Revision: v3.3.3 has been removed.
    Difference
    0.1%
    Check dated 2026-01-14T02:00:13.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Added a Locations section showing the California site and updated the page revision from v3.3.2 to v3.3.3. Removed the HHS Vulnerability Disclosure and the California Locations entry.
    Difference
    0.2%
    Check dated 2025-12-23T13:27:31.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is shown on the page, and Revision: v3.3.1 has been removed.
    Difference
    0.1%
    Check dated 2025-12-01T17:48:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Blinatumomab in ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Blinatumomab in ALL Clinical Trial page.